FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Sandoz Seeks Stricter Advair Bioequivalence in ANDAs

[ Price : $8.95]

Sandoz petitions FDA asking that it not approve generic copies of GlaxoSmithKlines asthma inhaler Advair Diskus 100/50 unless ANDA...

FDA Reviewers Question Trial Designs with Nocturia Drug

[ Price : $8.95]

FDA reviewers question clinical trial designs in a Serenity Pharmaceuticals NDA for SER120 (desmopressin nasal spray), which is pr...

Omnicare Pays $28 Million to Resolve Abbott Kickback Probe

[ Price : $8.95]

Omnicare agrees to pay $28 million to resolve allegations that it solicited and received kickbacks from Abbott Laboratories in exc...

Guide on ANDA Prior Approval Supplements

[ Price : $8.95]

Federal Register Notice: FDA makes available a guidance on ANDA Submissions Prior Approval Supplements Under GDUFA.

Workshop on Generic Drug Perceptions and Reality

[ Price : $8.95]

Federal Register Notice: FDA and Johns Hopkins University Center of Excellence in Regulatory Science and Innovation announce a 11/...

Public Meeting on Generic Drug User Fee Reauthorization

[ Price : $8.95]

FDA announces a 10/21 public meeting to hear public comments on the recent proposed agreement to reauthorize the generic drug user...

Royal Philips Cardia Transducer for Lumify Cleared

[ Price : $8.95]

FDA clears a Royal Philips 510(k) for the S4-1 cardiac transducer for Lumify, asmart-device diagnostic ultrasound solution.

FDA Guide on ANDA Prior Approval Supplements

[ Price : $8.95]

FDA releases a guidance on ANDA Submissions Prior Approval Supplements Under GDUFA that is intended to assist applicants preparin...

FDA Renews Dermatologic/Opthalmic Drugs Panel

[ Price : $8.95]

Federal Register Notice: FDA announces the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee for an additional t...

FDA Renews Antimicrobial Drugs Panel

[ Price : $8.95]

Federal Register Notice: FDA renews the Antimicrobial Drugs Advisory Committee for an additional two years beyond the charter expi...